重组Anti-HSF1 (phospho S326)抗体[EP1713Y]
Anti-HSF1 (phospho S326) antibody [EP1713Y]
- RabMAb
- Recombinant
- 了解详情
4
(1 Review)
|
(58 Publications)
Rabbit Recombinant Monoclonal HSF1 phospho S326 antibody. Suitable for Dot, WB and reacts with Synthetic peptide, Human samples. Cited in 58 publications.
查看别名
HSTF1, HSF1, Heat shock factor protein 1, HSF 1, Heat shock transcription factor 1, HSTF 1
- WB
Lab
Western blot - Anti-HSF1 (phospho S326) antibody [EP1713Y] (AB76076)
Blocking/Diluting Buffer and concentration : 5% NFDM /TBST
All lanes:
Western blot - Anti-HSF1 (phospho S326) antibody [EP1713Y] (ab76076) at 0.169 µg/mL
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with heat at 43℃ for 30 minutes whole cell lysate at 20 µg
Lane 3:
HeLa treated with heat at 43℃ for 30 minutes whole cell lysate. Then the membrane was incubated with alkaline phosphatase. at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.02 µg/mL
Predicted band size: 57 kDa
Observed band size: 82 kDa
false
- WB
Lab
Western blot - Anti-HSF1 (phospho S326) antibody [EP1713Y] (AB76076)
All lanes:
Western blot - Anti-HSF1 (phospho S326) antibody [EP1713Y] (ab76076) at 1/10000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) treated with heat (42 ℃) whole cell lysates at 20 µg
Lane 3:
HeLa (Human cervix adenocarcinoma epithelial cell) treated with heat (42 ℃) whole cell lysates. Then the membrane was incubated with phosphatase at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 82 kDa
false
- Dot
Unknown
Dot Blot - Anti-HSF1 (phospho S326) antibody [EP1713Y] (AB76076)
Dot blot analysis of HSF1 (phospho S326) peptide (Lane 1), HSF1 non-phospho peptide (Lane 2) labelling HSF1 (phospho S326) with purified ab76076 at 0.338 ug/mL. ab97051 (Peroxidase conjugated goat anti-rabbit IgG (H+L)) was used as the secondary antibody at 0.01 ug/mL.
Blocking and dilution buffer : 5% NFDM/TBST.
- WB
CiteAb
Western blot - Anti-HSF1 (phospho S326) antibody [EP1713Y] (AB76076)
Western Blotting using Anti-HSF1 (phospho S326) antibody [EP1713Y], ab76076. Publication image from Wang, C. et al., 2019, Nat Commun, 31699992. Legend direct from paper.
Hyperacetylation of NPC1 and proteostasis impact by SAHA. a SAHA leads hyperacetylation of both WT and I1061T-NPC1. Cell lysate of WT or I1061T/I1061T patient fibroblast was immunoprecipitated by acetylated-lysine (AcK) antibody and then recognized by NPC1 antibody through western blot. b SAHA impacts the expression of proteostasis components. Immunoblot analysis of SAHA-treated (10 µM for 48 h) I1061T/I1061T homozygous fibroblast (left panel) and quantification of total Hsf1, Hsf1 phosphorylated (Hsf1-P), BAG1, BAG2, BAG3, and HDAC7 (right panel) are shown. GAPDH was used as Western blot loading control. Data is presented as fold change to DMSO treatment (mean ± s.d., n = 3). P-values are indicated using student’s two tailed t-test (*p < 0.05, **p<0.01, ***p<0.001)
false
不同偶联物与剂型 (1)
-
Anti-HSF1 (phospho S326) antibody [EP1713Y] - BSA and Azide free
反应性数据
产品详情
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (58)
Recent publications for all applications. Explore the full list and refine your search
Nanomaterials (Basel, Switzerland) 14: PubMed39404291
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 63:2414-2424 PubMed39254477
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1320040 PubMed38333010
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107864 PubMed37766982
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:407 PubMed36195608
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed36010586
2022
Applications
Unspecified application
Species
Unspecified reactive species
Structure (London, England : 1993) 30:1190-1207.e5 PubMed35714602
2022
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology and applied pharmacology 445:116041 PubMed35504338
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biotechnology 64:873-887 PubMed35218516
2022
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 63:30 PubMed35201262
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com